This two-day symposium will bring together basic and clinical scientists to discuss the role of perturbed RNA metabolism in neurological diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), spinal muscular atrophy (SMA), and repeat expansion disorders. More…
J. Paul Taylor, MD, Ph.D,
St Jude Children's Research Hospital, Memphis, USA
Paul Taylor is an Investigator of the Howard Hughes Medical Institute and is also the Edward F. Barry Endowed Chair of the Department of Cell and Molecular Biology St. Jude Children’s Research Hospital. He earned his M.D. and Ph.D. degrees from Jefferson Medical College and trained in Neurology at the University of Pennsylvania. After a Neurogenetics Fellowship at the NIH, Dr. Taylor joined the Neurology faculty at the University of Pennsylvania where he established a neurogenetics clinic and a basic research program studying the molecular genetics of neurological diseases before moving to St. Jude in 2008. Dr. Taylor was awarded the Derek Denny-Brown Neurological Scholars Award from the American Neurological Association in 2013 and was elected to the American Association of Physicians in 2015.
Fen-Biao Gao, Ph.D
University of Massachusetts Medical School, USA
Fen-Biao Gao is the inaugural Governor Paul Cellucci Chair in Neuroscience Research and Vice Chair of Research in the Department of Neurology at the University of Massachusetts Medical School (UMMS). He did his PhD study on neuronal RNA binding proteins at Duke University. Then he performed his postdoctoral trainings in developmental neurobiology with Dr. Martin Raff at the University College London and Dr. Yuh-Nung Jan at the University of California San Francisco (UCSF). In 2000, he established his own laboratory at the Gladstone Institute of Neurological Disease at UCSF and then moved to UMMS in 2010. His laboratory studied molecular mechanisms of dendritic morphogenesis and in recent years uses Drosophila, transgenic mice and patient-specific induced pluripotent stem cells (iPSCs) as experimental systems to investigate pathogenic mechanisms and therapeutic targets of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). He was a Sloan Research Fellow in Neuroscience, a Klingenstein Fellow in Neuroscience and a recipient of the McKnight Neuroscience of Brain Disorders Award. He received a Javits Neuroscience Investigator Award from NIH in 2017.